Literature DB >> 9815563

Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.

J van Rijn1, J van den Berg.   

Abstract

The nuclear enzyme topoisomerase II, which is involved in replication, transcription, and probably repair of DNA, can be inhibited by a number of flavonoids. In conjunction with X-rays, three of these compounds were tested as to their effects on Reuber H35 hepatoma cells. In this combination, the isoflavone genistein, the flavone apigenin, and the flavonol quercetin caused an enhancement of radiation-induced cell death. This enhanced cytotoxicity was only observed when the flavonoids were applied following an irradiation treatment and is attributed to decreased repair of DNA radiation damage with a concomitant reduction of the rate of cell repopulation. Fractionated irradiations, given as five sequences of 3 Gy each over a period of 5 days, reduced the surviving cell population only by a factor of 20, whereas the continuous presence of genistein during radiation sequences resulted in a reduction of at least a factor of 10,000. Thus, these flavonoids not only seem to act as radiation enhancers but also exhibit potential antitumor activities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9815563

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  10 in total

Review 1.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

2.  Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes.

Authors:  Hari Krishnan Nair; Kesava V K Rao; Ravikumar Aalinkeel; Supriya Mahajan; Ram Chawda; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 3.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

4.  In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.

Authors:  Robert Michael Hermann; Hendrik Andreas Wolff; Hubertus Jarry; Paul Thelen; Carsten Gruendker; Margret Rave-Fraenk; Heinz Schmidberger; Hans Christiansen
Journal:  Radiat Oncol       Date:  2008-07-14       Impact factor: 3.481

5.  A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer.

Authors:  Tonny Lagerweij; Lotte Hiddingh; Dennis Biesmans; Matheus H W Crommentuijn; Jacqueline Cloos; Xiao-Nan Li; Mari Kogiso; Bakhos A Tannous; W Peter Vandertop; David P Noske; Gertjan J L Kaspers; Tom Würdinger; Esther Hulleman
Journal:  Oncotarget       Date:  2016-06-14

6.  Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity.

Authors:  Lich Thi Nguyen; Yeon-Hee Lee; Ashish Ranjan Sharma; Jong-Bong Park; Supriya Jagga; Garima Sharma; Sang-Soo Lee; Ju-Suk Nam
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

7.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

8.  Rutin and Quercetin Counter Doxorubicin-Induced Liver Toxicity in Wistar Rats via Their Modulatory Effects on Inflammation, Oxidative Stress, Apoptosis, and Nrf2.

Authors:  Osama M Ahmed; Mohammed H Elkomy; Hanaa I Fahim; Mohamed B Ashour; Ibrahim A Naguib; Badrah S Alghamdi; Heba Uallah R Mahmoud; Noha A Ahmed
Journal:  Oxid Med Cell Longev       Date:  2022-07-27       Impact factor: 7.310

Review 9.  Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy.

Authors:  Sihan Du; Ying Liu; Yuan Yuan; Yuran Wang; Yanfang Chen; Shuai Wang; Yuhua Chi
Journal:  Front Cell Dev Biol       Date:  2022-08-10

10.  Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity.

Authors:  Dong Chen; Fu-Ju Chou; Yuhchyau Chen; Chi-Ping Huang; Hao Tian; Yaqin Wang; Yuanjie Niu; Bosen You; Shuyuan Yeh; Nianzeng Xing; Chawnshang Chang
Journal:  J Exp Clin Cancer Res       Date:  2022-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.